LATS2 and neoplasm: In the univariate analyses, LATS2 expression (HR: 0.087, 95% CI: 0.035–0.216, P < 0.001), tumor differentiation (HR: 2.672, 95% CI: 1.630–4.379, P < 0.001), TNM stage (HR: 2.193, 95% CI: 1.575–3.054, P < 0.001), T stage (HR: 6.693, 95% CI: 2.705–16.560, P < 0.001), N stage (HR: 1.479, 95% CI: 1.213–1.804, P < 0.001), M stage (HR: 6.418, 95% CI: 3.470–11.869, P < 0.001), and preoperative CEA level (HR: 2.593, 95% CI: 1.501–4.478, P = 0.001) were significantly correlated with OS.